At Really, our vision is simple and ambitious - A world that no longer suffers from Alzheimer's.VisionBy better understanding language, and how our use of it changes over time, we at Really hope to detect Alzheimer's and other forms of neurodegeneration some 20 years earlier than currently possible. We hope to improve all aspects of the therapeutic lifecycle: improve research by finding the best clinical trial candidates, improve therapies from the fact that we act much earlier and compress the product life cycle of drug discovery and development. We want to improve life outcomes by affording treatments the highest potential to succeed. TechWe ingest all forms of written language (email, SMS, social media, etc.), construct a baseline of an individual's mental state from derived linguistic biomarkers, and monitor, passively and non-invasively for neurodegeneration over time. We are building our Machine Learning and Artificial Intelligence engine from collaboration with leading partners in this space.TeamAn experienced team from startup, corporate, tech, people, branding, AI and growth business backgrounds - augmented by a well established, industry leading team of advisors, representing the broader machine learning and MedTech ecosystems.

Website: aperim.com

Employees: 5 - 9

HQ: N/A

Location: Sydney, N/A, AU

Revenue: Not Available

Are you looking for contact information for Aperim? You've come to the right place! ConnectPlex is the premier AI-powered B2B lead generation platform, and we have all the contact details you need to get in touch with key decision-makers at Aperim. Our cutting-edge algorithms and extensive database of company information ensure that you can quickly and easily find the contact information you need to grow your business. Whether you're looking to partner with Aperim or pitch your products or services to their team, ConnectPlex is the perfect solution for all your B2B lead generation needs. Our platform is designed to help you connect with the right people at the right time, and our AI-powered algorithms ensure that you get the most accurate and up-to-date contact information available. So why wait? Start your search for Aperim contact information today and see the difference that ConnectPlex can make for your business!

Aperim is a cutting-edge technology firm based in Sydney, Australia, with a bold vision to eradicate Alzheimer's disease and other forms of neurodegeneration. The company's innovative approach involves analyzing written language to detect neurodegeneration up to 20 years earlier than current methods. By leveraging machine learning and artificial intelligence, Aperim aims to improve all aspects of the therapeutic lifecycle, from research to treatment outcomes. Led by an experienced team with diverse backgrounds in startup, corporate, tech, and growth business, Aperim is poised to revolutionize the field of neurodegeneration detection and treatment. The company's commitment to collaboration and innovation is reflected in its partnerships with leading experts in the field, ensuring that the latest advancements in machine learning and MedTech are integrated into its platform. With a strong focus on design and user experience, Aperim is set to make a significant impact in the lives of those affected by neurodegenerative diseases.

At Really, our goal is to make a world where Alzheimer's disease no longer exists. We want to do this by studying how people use language and how it changes over time. By doing this, we hope to detect Alzheimer's and other brain diseases 20 years earlier than we can now. We want to improve the way drugs are developed and make sure they work better. We want to help people live better lives by giving them the best chance to get better. We look at everything people write, like emails, texts, and social media. We use this information to understand how people's minds are working and see if there are any changes over time. We are working with really smart people and using technology to make our system even better. We have a team of people who have worked in different areas, like starting new businesses, working for big companies, and creating new products. We also have a group of experts who are very knowledgeable about artificial intelligence and medicine. Together, we are working to make our system the best it can be.